Muhammad Tayyab Mumtaz

Suggest Changes

Writes About:

Learn More
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide (ATO) and thalidomide. Seven patients responded including one complete hematologic and cytogenetic response(More)